May 11, 2020
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Ms. Irene Paik
Statement on Form S-3
Dear Mr. Gabor,
Pursuant to Rule 461 of the General Rules and
Regulations under the Securities Act of 1933, as amended, the
undersigned, VistaGen Therapeutics, Inc., a Nevada corporation (the
“Registrant”), hereby requests acceleration of the
effective date of the Registration Statement referred to above so
that it may become effective at 10:00 a.m. Eastern Standard Time on
May 13, 2020, or as soon as practicable
grant of our request to accelerate effectiveness, we would
appreciate your communicating with our counsel, Disclosure Law
Group, a Professional Corporation, by calling Ms. Jessica R.
Sudweeks at (619) 272-7063, to confirm the exact time at which the
Registration Statement was declared effective.
/s/ Shawn K. Singh
and Chief Executive Officer
Law Group, a Professional Corporation